Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6

American Journal of Surgical Pathology

Volumn 34, Issue 3, 2010, Pages 341-354

  Kleinschmidt Demasters, Bette Kay ^a   Alassiri, Ali H ^c   Birks, Diane K ^a,b   Newell, Kathy L ^d   Moore, Wayne ^c   Lillehei, Kevin O ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Childrens Hospital   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

BAF 47; Claudin 6; Glioblastoma; INI 1; MIB 1; P53

Indexed keywords

CLAUDIN 6; DNA BINDING PROTEIN; MEMBRANE PROTEIN; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CHEMISTRY; CHILD; CHROMOSOME 22; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EPITHELIOID CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MONOSOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTION AND FORECASTING; RHABDOID TUMOR;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOMES, HUMAN, PAIR 22; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; EPITHELIOID CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MONOSOMY; PREDICTIVE VALUE OF TESTS; RHABDOID TUMOR; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77649212129     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181ce107b     Document Type: Article

References (35)

1. Abuazza G, Becker A, Williams SS, et al. Claudins 6, 9, and 13 are developmentally expressed renal tight junction proteins. Am J Physiol Renal Physiol. 2006;291:F1132-F1141.
2. Birks DK, Kleinschmidt-Demasters BK, Donson AM, et al. Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors. Brain Pathol. 2009 [Epub ahead of print].
3. Brat DJ, Scheithauer BW, Medina-Flores R, et al. Infiltrative astrocytomas with granular cell features (granular cell astrocytomas): a study of histopathologic features, grading, and outcome. Am J Surg Pathol. 2002;26:750-757.
4. Burger PC, Yu IT, Tihan T, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol. 1998;22: 1083-1092.
5. Chorny JA, Evans LC, Kleinschmidt-DeMasters BK. Cerebral granular cell astrocytomas: a Mib-1, bcl-2, and telomerase study. Clin Neuropathol. 2000;19:170-179.
6. Fuller CE, Pfeifer J, Humphrey P, et al. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic? Hum Pathol. 2001;32:1102-1108.
7. Fuller GN, Goodman JC, Vogel H, et al. Epithelioid glioblastoma: a distinct clinicopathologic entity. J Neuropathol Exp Neurol. 1998; 57:501.
8. Fung KM, Perry A, Payner TD, et al. Rhabdoid glioblastoma in an adult. Pathology. 2004;36:585-587.
9. Giannini C, Scheithauer BW, Burger PC, et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer. 1999;85: 2033-2045.
10. Judkins AR, Burger PC, Hamilton RL, et al. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J. Neuropathol. Exp Neurol. 2005;64:391-397.
11. Judkins AR, Eberhart CG, Wesseling P. Atypical teratoid/rhabdoid tumour. In: Louis DN, Ohgaki H, Wiestler OD, et al, eds. WHO Classification of Tumours of the Central Nervous System. Albany, New York: WHO Publications Center; 2007:147-149.
12. Kepes JJ. Astrocytomas: old and newly recognized variants, their spectrum of morphology and antigen expression. Can J Neurol Sci. 1987;14:109-121.
13. Kepes JJ. Pleomorphic xanthoastrocytomas (PXA-s) and lipidized glioblastomas. Brain Tumor Pathol. 1991;8:1-4.
14. Kepes JJ, Rubinstein LJ. Malignant gliomas with heavily lipidized (foamy) tumor cells: a report of three cases with immunoperoxidase study. Cancer. 1981;47:2451-2459.
15. Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer. 1979;44: 1839-1852.
16. Kepes JJ, Fulling KH, Garcia JH. The clinical significance of "adenoid" formations of neoplastic astrocytes, imitating metastatic carcinoma, in gliosarcomas. A review of five cases. Clin Neuropathol. 1982;1:139-150.
17. Kleihues P, Burger PC, Aldape KD, et al. Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, et al, eds. WHO Classification of Tumours of the Central Nervous System. Albany, New York: WHO Publications Center; 2007:33-49.
18. Kleinschmidt-DeMasters BK, Meltesen L, McGavran L, et al. Characterization of glioblastomas in young adult patients. Brain Pathol. 2006;16:273-286.
19. Kornfeld M. Granular cell glioblastoma: a malignant granular cell neoplasm of astrocytic origin. J Neuropathol Exp Neurol. 1986;45:447-462.
20. Lath R, Unosson D, Blumbergs P, et al. Rhabdoid glioblastoma: a case report. J Clin Neurosci. 2003;10:325-328.
21. Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, et al. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med. 2003;127:1187-1191.
22. Miller CR, Dunham CP, Scheithauer BW, et al. Significance of necrosis in grading of oligodendroglial neoplasm: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. J Clin Oncol. 2006;24:5419-5426.
23. Mork SJ, Rubinstein LJ, Kepes JJ. Patterns of epithelial metaplasia in malignant gliomas. I. Papillary formations mimicking medulloepithelioma. J Neuropathol Exp Neurol. 1988;47:93-100.
24. Mork SJ, Rubinstein LJ, Kepes JJ, et al. Patterns of epithelial metaplasia in malignant gliomas. II. Squamous differentiation of epithelial-like formations in gliosarcomas and glioblastomas. J Neuropathol Exp Neurol. 1988;47:101-118.
25. Ozolek JA, Finkelstein SD, Couce ME. Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature. Mod Pathol. 2004;17: 739-745.
26. Perry A, Aldape KD, George DH, et al. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer. 2004;101:2318-2326.
27. Perry A, Fuller CE, Judkins AR, et al. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol. 2005;18:951-958.
28. Rodriguez FJ, Scheithauer BW, Port JD. Unusual malignant glioneuronal tumors of the cerebrum of adults: a clinicopathologic study of three cases. Acta Neuropathol. 2006;112:727-737.
29. Rodriguez FJ, Scheithauer BW, Giannini C, et al. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma. A comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-2789.
30. Rosenblum MK, Erlandson RA, Budzilovich GN. The lipid-rich epithelioid glioblastoma. Am J Surg Pathol. 1991;15:925-934.
31. Troy TC, Arabzadeh A, Yerlikaya S, et al. Claudin immunolocalization in neonatal mouse epithelial tissues. Cell Tissue Res. 2007; 330:381-388.
32. Turksen K, Troy TC. Claudin-6: a novel tight junction molecule is developmentally regulated in mouse embryonic epithelium. Dev Dyn. 2001;222:292-300.
33. Varlet P, Soni D, Miquel C, et al. New variants of malignant glioneuronal tumors a clinicopathological study of 40 cases. Neurosurgery. 2004;55:1377-1392.
34. Wyatt-Ashmead J, Kleinschmidt-DeMasters BK, Hill DA, et al. Rhabdoid glioblastoma. Clin Neuropathol. 2001;20:248-255.
35. Zhao L, Yaoita E, Nameta M, et al. Claudin-6 localized in tight junctions of rat podocytes. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1856-R1862.